Leonteq Securities’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Leonteq Securities's HAE Position: Q3 2026 in Review
Leonteq Securities held its Haemonetics (HAE) position steady in Q3 2026 at 9 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #1184.
Leonteq Securities first reported a position in HAE in Q4 2024 and has held it in 8 quarters since. The position peaked at $246K in Q2 2025. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Leonteq Securities held 9 shares of Haemonetics worth $948 as of Q3 2026.
- Leonteq Securities left its Haemonetics share count unchanged in Q3 2026.
- Haemonetics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1184 holding.
- Leonteq Securities first reported a position in Haemonetics in Q4 2024 and has held it in 8 quarters since.
- Leonteq Securities's Haemonetics position peaked at $246K in Q2 2025.
- 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.